Related Experiment Video
Updated: Mar 12, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Immune activation, smoking, and vaccine response
Mehwish Younas1, Fabrice Carrat, Corinne Desaint
1aInstitute of Human Genetics, CNRS UPR1142, Montpellier, France bINSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universités, UPMC Paris 06 cAssistance Publique Hôpitaux de Paris (AP-HP), Public Health Unit, Hôpital Saint-Antoine dSorbonne Paris Cité, AP-HP, CIC Cochin Pasteur, Hôpital Cochin, Université Paris Descartes, Paris eInserm, F-CRIN, I-REIVAC, Paris fMontpellier University, Montpellier gImmunology Department, University Hospital, Nîmes, France. *Study group members are listed after the text. †OL and PC contributed equally to this work.
Abstract:
Here, we tested the hypothesis that chronic immune activation might fuel interindividual variability in vaccine response in the model of hepatitis B virus vaccine in HIV-1-infected adults. We observed that the marker of inflammation soluble tumour necrosis factor receptor I (sTNFRI) is predictive for vaccine efficiency. We also established that the link between tobacco smoking and impaired vaccine response might be mediated by inflammation. These data are a step forward in personalized vaccination.
Related Concept Videos
Vaccinations
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Allergic Drug Reactions
Cell-mediated Immune Responses
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

